Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
FDA Fast-Tracks Liquidia Drug for Painful Systemic Sclerosis Complication ↗
Via Benzinga
Exposures Product Safety
News headline image
Kaplan Fox Deadline Alert: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Have Until September 28, 2026 to Seek a Lead Plaintiff Role
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
FondCircle Launches FBP-A2 to Make Blood Pressure Tracking Simpler During Pregnancy and Beyond
Via Press Release Distribution Service
Tickers ARM
Exposures Product Safety
News headline image
EXCLUSIVE: Modular Medical Secures FDA Clearance for Pivot Software Upgrades ↗
Via Benzinga
Exposures Product Safety
News headline image
FondCircle Launches FBP-A2 to Make Blood Pressure Tracking Simpler During Pregnancy and Beyond
Via Get News
Tickers ARM
Exposures Product Safety
News headline image
Here's Why Ionis Pharmaceuticals' Steep Sell-off Was Overdone ↗
Via The Motley Fool
Tickers AZN IONS RHHBY
Exposures Product Safety
News headline image
ISO 8573-1 Class 0: What the Test Report Really Proves
Via AB Newswire
Exposures Climate Product Safety
News headline image
Heat Treatment Workshop Production Standard Audit Points
Via AB Newswire
Topics Supply Chain
Exposures Product Safety Regulatory Supply Chain
News headline image
NuYOU360 Brings VCSEL Laser Technology to At-Home Red Light Therapy Masks and Publishes the Full Specifications
Via AB Newswire
Exposures Product Safety
News headline image
Belite Bio Wins FDA Priority Review for Tinlarebant in Stargardt Disease ↗
Via MarketBeat
Tickers BLTE
Exposures Product Safety
News headline image
Q2 Earnings Highs And Lows: DexCom (NASDAQ:DXCM) Vs The Rest Of The Patient Monitoring Stocks
Via StockStory
Topics Artificial Intelligence
Tickers DXCM
Exposures Artificial Intelligence Product Safety
News headline image
Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Via Newsfile
Topics Lawsuit
Tickers CAPR SAP
Exposures Financial Legal Product Safety
News headline image
America’s New Drug Dealers Have Moved from Street Corners to the Internet – and the FDA is Letting Them
Via NewsUSA
Topics Law Enforcement
Exposures Legal Product Safety
News headline image
Kaplan Fox Announces a Securities Class Action Filed Against Capricor Therapeutics, Inc. (NASDAQ: CAPR) - Lead Plaintiff Deadline is September 28, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
JUUL Pods vs Cigarettes: Nicotine Levels, Side Effects & Usage Guide Released
Via Press Release Distribution Service
Exposures Product Safety
News headline image
Atlanta Vape & Nicotine Pouch Delivery: Online Options, Pricing Guide Released
Via Press Release Distribution Service
Exposures Product Safety
News headline image
SciSparc Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation for Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies
Via TheNewswire.com
Tickers SPRC TSX-V:NTLX
Exposures Product Safety
NetworkNewsBreaks – Regentis Biomaterials Ltd.’s (NYSE American: RGNT) GelrinC Advances Toward New Era of Regenerative Orthopedic Care
Via Investor Brand Network
Tickers RGNT
Exposures Product Safety
News headline image
CAPR Stock Drop: Robbins LLP Reminds Investors They May Be Eligible to Lead the Class Action Against Capricor Therapeutics, Inc.
Via Newsfile
Topics Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
News headline image
VivoSim Labs (NASDAQ: VIVS) Opens New Pharma Opportunity
Via AB Newswire
Tickers FAMI GELS VIOT VIVK VIVS
Exposures Product Safety
News headline image
uniQure Filed for Huntington's Approval. Acceptance Is the Catalyst, Analyst Says ↗
Via Benzinga
Exposures Product Safety
News headline image
UniQure's Embattled Huntington's Gene Therapy Clears A Key Hurdle ↗
Via Investor's Business Daily
Exposures Product Safety
News headline image
Fraudulent Weight Loss Drugs: FDA Warns Against Mislabeled GLP-1 Medications ↗
Via Benzinga
Exposures Product Safety
News headline image
OS Therapies Provides OST-HER2 Metastatic Osteosarcoma Program Update and Announces Upcoming Conference Attendance
Via Newsfile
Tickers OSTX
Exposures Product Safety
News headline image
Inbec Tablet Price for Global Supply and Lead-Time Planning - Oddway ↗
Via Talk Markets
Topics Supply Chain
Exposures Product Safety Supply Chain
News headline image
Prescription Medicines, Peptides, Hormones and Weight-Loss Treatments: A Safety Guide ↗
Via Talk Markets
Exposures Product Safety
News headline image
Kaplan Fox is Investigating Medline Inc. (NASDAQ: MDLN) for Possible Securities Law Violations
Via NewMediaWire
Tickers BAC MDLN
Exposures Product Safety
News headline image
Kaplan Fox Announces an Investigation into Fulcrum Therapeutics, Inc. (NASDAQ: FULC) for Possible Securities Law Violations
Via NewMediaWire
Tickers FULC
Exposures Product Safety
News headline image
Kaplan Fox Continues to Remind Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors of the Lead Plaintiff Deadline on September 28, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
Fractyl Health Eyes 2028 Revita Launch for Post-GLP-1 Weight Maintenance ↗
Via MarketBeat
Tickers GUTS
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.